Abstract
N-(2,6-Dichloro-m-tolyl)anthranilic acid (CI-583) is an anti-inflammatory agent with an acute oral potency 4.9 (2.4 to 10)95% times that of indomethacin, 9.1 (4.7 to 18)95% times that of flufenamic acid, 15 (9.6 to 23)95% times that of phenylbutazone, 29 (17 to 50)95% times that of mefenamic acid, 110 (61 to 190)95% times that of aminopyrine and 150 (88 to 240)95% times that of aspirin as determined in the UV-erythema assay in guinea pigs. In the subcutaneous cotton pellet test in rats it exhibits a significant though shallowly dose-graded antigranulation effect paralleling that of phenylbutazone at a subacute oral potency 14 (2.1 to 92)95% times that of phenylbutazone. There was no evidence of adrenal dependence or corticoid-like effects at effective and nontoxic dose levels. The agent antagonizes yeast-induced pyresis in rats with a potency probably >10 times that of phenylbutazone by the oral route. Like flufenamic acid and phenylbutazone, and unlike mefenamic acid, it had less, if any, antinociceptive effect in quantitative tail-pinching experiments with rats than aminopyrine.
Footnotes
- Accepted January 26, 1965.
- The Williams & Wilkins Comapny
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|